Yu Chen

29.5k total citations · 3 hit papers
171 papers, 9.4k citations indexed

About

Yu Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Yu Chen has authored 171 papers receiving a total of 9.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Molecular Biology, 77 papers in Pulmonary and Respiratory Medicine and 27 papers in Oncology. Recurrent topics in Yu Chen's work include Prostate Cancer Treatment and Research (36 papers), Ubiquitin and proteasome pathways (11 papers) and Ferroptosis and cancer prognosis (10 papers). Yu Chen is often cited by papers focused on Prostate Cancer Treatment and Research (36 papers), Ubiquitin and proteasome pathways (11 papers) and Ferroptosis and cancer prognosis (10 papers). Yu Chen collaborates with scholars based in United States, China and Israel. Yu Chen's co-authors include Charles L. Sawyers, Howard I. Scher, John Wongvipat, Dong Gao, Nicola J. Clegg, Philip A. Watson, Vivek Arora, Derek S. Welsbie, Wolfgang G. Junger and Hans Clevers and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Yu Chen

160 papers receiving 9.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer

2009 1.7k citations Chris Tran, Samedy Ouk et al. Science profile →
Identification of Multipotent Luminal Progenitor Cells in Human Prostate Organoid Cultures

2014 539 citations John Wongvipat, Dong Gao et al. profile →
Organoid culture systems for prostate epithelial and cancer tissue

2016 447 citations Dong Gao, Charles L. Sawyers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu Chen United States	45	4.3k	3.7k	2.0k	1.7k	1.4k	171	9.4k
Atsushi Mizokami Japan	49	3.4k 0.8×	3.4k 0.9×	2.4k 1.2×	1.4k 0.8×	1.1k 0.8×	386	8.8k
Bruce Montgomery United States	47	3.2k 0.7×	6.1k 1.6×	3.6k 1.8×	3.2k 1.9×	1.0k 0.7×	244	10.4k
Marc K. Halushka United States	56	4.4k 1.0×	2.4k 0.7×	1.8k 0.9×	2.2k 1.4×	1.9k 1.3×	215	11.8k
Anders Bergh Sweden	58	4.7k 1.1×	4.3k 1.2×	2.1k 1.1×	2.3k 1.4×	1.2k 0.8×	345	12.4k
Phillip A. Dennis United States	49	7.6k 1.8×	2.5k 0.7×	4.6k 2.3×	2.2k 1.3×	538 0.4×	137	12.4k
Maria Tsokos United States	69	5.3k 1.2×	3.5k 0.9×	3.7k 1.8×	1.4k 0.9×	828 0.6×	244	15.2k
Athanassios P. Kyritsis United States	48	3.2k 0.7×	1.5k 0.4×	2.0k 1.0×	1.1k 0.7×	1.2k 0.8×	173	7.9k
Diether Lambrechts Belgium	53	6.3k 1.5×	2.1k 0.6×	3.9k 2.0×	2.8k 1.7×	1.2k 0.8×	296	14.4k
Candace S. Johnson United States	49	2.9k 0.7×	1.0k 0.3×	1.8k 0.9×	959 0.6×	1.6k 1.1×	176	8.1k
Toshihiro Nukiwa Japan	56	4.3k 1.0×	5.7k 1.5×	4.1k 2.0×	1.7k 1.0×	567 0.4×	252	12.8k

Countries citing papers authored by Yu Chen

Since Specialization

Citations

This map shows the geographic impact of Yu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Chen more than expected).

Fields of papers citing papers by Yu Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Chen. The network helps show where Yu Chen may publish in the future.

Co-authorship network of co-authors of Yu Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Chen. A scholar is included among the top collaborators of Yu Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Chen. Yu Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Tingting, Zhuquan Su, Liya Lu, et al.. (2024). Efficacy and Safety of Platelet-Rich Plasma on Bronchopleural Fistula: A Pilot Prospective Cohort Study. Archivos de Bronconeumología. 61(3). 132–137. 1 indexed citations

Huber, Thomas, et al.. (2024). The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence. Science Signaling. 17(854). eadp3967–eadp3967. 1 indexed citations

Su, Qian, Yuchun Li, Xinyuan Liu, et al.. (2024). Rewiring of Uric Acid Metabolism in the Intestine Promotes High-Altitude Hypoxia Adaptation in Humans. Molecular Biology and Evolution. 41(11). 6 indexed citations

Ran, Leili, Amish J. Patel, Juan Yan, et al.. (2024). MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor. Clinical Cancer Research. 30(22). 5154–5165. 2 indexed citations

Li, Fei, Xudong Xing, Xiang‐Ming Wang, et al.. (2024). Sex differences orchestrated by androgens at single-cell resolution. Nature. 629(8010). 193–200. 30 indexed citations

Chen, Wei, et al.. (2023). Integrative analysis of Iso-Seq and RNA-seq reveals dynamic changes of alternative promoter, alternative splicing and alternative polyadenylation during Angiotensin II-induced senescence in rat primary aortic endothelial cells. Frontiers in Genetics. 14. 1064624–1064624. 2 indexed citations

Han, Xinwei, et al.. (2023). Characteristics of m⁶A-related LncRNAs in breast cancer as prognostic biomarkers and immunotherapy. Journal of Cancer. 14(15). 2919–2930. 1 indexed citations

Liu, Xiaojing, Yu Chen, Shengkun Wang, et al.. (2023). Identification and Characterization of the AREB/ABF/ABI5 Gene Family in Sandalwood (Santalum album L.) and Its Potential Role in Drought Stress and ABA Treatment. Forests. 14(8). 1691–1691. 10 indexed citations

Ma, Xiaodi, Yu Chen, Xiangping Qu, et al.. (2022). The Role of DNA Damage and Repair in Idiopathic Pulmonary Fibrosis. Antioxidants. 11(11). 2292–2292. 17 indexed citations

10.

Mao, Ninghui, Zeda Zhang, Young Sun Lee, et al.. (2021). Defining the therapeutic selective dependencies for distinct subtypes of PI3K pathway-altered prostate cancers. Nature Communications. 12(1). 5053–5053. 18 indexed citations

11.

Dhimolea, Eugen, Ricardo De Matos Simoes, Xiang Weng, et al.. (2020). Pleiotropic Mechanisms Drive Endocrine Resistance in the Three-Dimensional Bone Microenvironment. Cancer Research. 81(2). 371–383. 12 indexed citations

12.

Ceraudo, Emilie, Tyler D. Hitchman, Amanda R. Moore, et al.. (2020). Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling. Journal of Biological Chemistry. 296. 100163–100163. 32 indexed citations

13.

Mao, Ninghui, Dong Gao, Wenhuo Hu, et al.. (2020). Oncogenic ERG Represses PI3K Signaling through Downregulation of IRS2. Cancer Research. 80(7). 1428–1437. 8 indexed citations

14.

He, Yundong, Yinhui Yang, Zhenqing Ye, et al.. (2018). TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53 -Mutated Prostate Cancer. Clinical Cancer Research. 24(18). 4551–4565. 51 indexed citations

15.

Ran, Leili, Devan Murphy, Jessica Sher, et al.. (2017). ETV1-Positive Cells Give Rise to BRAFV600E -Mutant Gastrointestinal Stromal Tumors. Cancer Research. 77(14). 3758–3765. 12 indexed citations

16.

Ran, Leili, Inna Sirota, Zhen Cao, et al.. (2015). Combined Inhibition of MAP Kinase and KIT Signaling Synergistically Destabilizes ETV1 and Suppresses GIST Tumor Growth. Cancer Discovery. 5(3). 304–315. 93 indexed citations

17.

Cato, Laura, Antje Neeb, Claudia Muhle‐Goll, et al.. (2014). Coregulator Control of Androgen Receptor Action by a Novel Nuclear Receptor-binding Motif. Journal of Biological Chemistry. 289(13). 8839–8851. 40 indexed citations

18.

Duca, Danny Del, et al.. (2011). Abstract 10257: Nuclear Angiotensin-II Receptor Gene Expression in Cardiac Fibroblasts: Receptor Subtype-Specific Differential Role of IP-3-Receptor (IP3R) Related and Nitric Oxide Signaling. Circulation. 124. 1 indexed citations

19.

Welsbie, Derek S., Jin Xu, Yu Chen, et al.. (2009). Histone Deacetylases Are Required for Androgen Receptor Function in Hormone-Sensitive and Castrate-Resistant Prostate Cancer. Cancer Research. 69(3). 958–966. 144 indexed citations

20.

Tran, Chris, Samedy Ouk, Nicola J. Clegg, et al.. (2009). Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer. Science. 324(5928). 787–790. 1689 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact